A paper released by OIST's G0 Cell Unit has identified that the common immunosuppressant chemical rapamycin has more potential uses for medicine.
The study, published in Open Biology, explores the chemical's ability to reverse the effects of mutation in yeast cells, effectively "curing" the cells by restoring their normal function.
